Feinsod Matthew 4
4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Feb 13, 2019
Insider Transaction Report
Form 4
Feinsod Matthew
Interim Chief Medical Officer
Transactions
- Award
Common Stock
2019-02-11+2,000→ 50,078 total - Tax Payment
Common Stock
2019-02-11$3.29/sh−791$2,602→ 49,287 total
Footnotes (1)
- [F1]The common stock vested immediately upon grant.